We are live on
!
Find out more
OFM
Omega Fund Management Portfolio holdings
AUM
$163M
1-Year Est. Return
107.06%
This Fund
S&P 500
This Quarter
Est. Return
+22.49%
1 Year Est. Return
+107.06%
3 Year Est. Return
+111.75%
5 Year Est. Return
+84.24%
10 Year Est. Return
+495.59%
AUM
$231M
AUM Growth
+$13.9M
(+6.4%)
Cap. Flow
-$6.83M
Cap. Flow
% of AUM
-2.95%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$2.43M |
| 2 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$2.43M |
| 3 |
AKAO
Achaogen Inc
AKAO
|
+$1.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.15% |
Similar funds
HCCM
PBO
PCR
BCM
IVGAI
CC
TCGDR
IPWA
Omega Fund Management's Q1 2015 Portfolio in Review
As of Q1 2015, Omega Fund Management held 7 positions worth $231M, up 6.4% from $217M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 0%. Omega Fund Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 58% a quarter earlier.
- Omega Fund Management's biggest Q1 2015 reduction was Dicerna Pharmaceuticals, Inc., cutting an estimated $2.43M.
- Omega Fund Management's ten largest holdings make up 100% of its $231M portfolio in Q1 2015.
- Omega Fund Management opened 0 new positions and closed 0 in Q1 2015.
- Omega Fund Management's portfolio value rose 6.4% quarter-over-quarter to $231M.
Based on Omega Fund Management's 13F filing for Q1 2015, filed 11 May 2015.